Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Contraception|October 1, 1980
Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetateJ Kremer, H W de Bruijn, F R HindriksGynecologic Oncology|September 1, 1984
Circulating antibodies against human chorionic gonadotropin following trophoblastic diseaseH W de Bruijn, A Groenhuis, J G AaldersAnalytical and Quantitative Cytology and Histology|February 1, 1997
Quantification of vascular density and of lumen and vessel morphology in endometrial carcinoma. Evaluation of their relation to serum levels of tissue polypeptide-specific antigen and CA-125F Willemse, M Nap, H W de Bruijn, et al.British Journal of Obstetrics and Gynaecology|July 1, 1978
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the NetherlandsW J Kleijer, H W De Bruijn, N J LeschotPrenatal Diagnosis|December 1, 1993
Maternal serum CA 125 levels in pregnancies with chromosomally-normal and -abnormal fetuses. Dutch Working Party on Prenatal DiagnosisJ M Van Lith, A Mantingh, H W De BruijnPrenatal Diagnosis|February 1, 1989
False-negative amniotic fluid acetylcholinesterase in a case of meningo-encephaloceleA Boogert, J G Aarnoudse, H W De Bruijn, et al.Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1990
Doubling time and hCG score for the early diagnosis of ectopic pregnancy in asymptomatic womenD J Tinga, J J van Lier, H W de BruijnExperimental and Clinical Immunogenetics|January 1, 1984
Immunoglobulin allotypes in patients with epithelial ovarian cancerT Ockhuizen, J Westra, J G Aalders, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 7, 1999
Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormonesH F Kauffman, H Hovenga, H W de Bruijn, et al.Current Opinion in Obstetrics & Gynecology|February 1, 1997
The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancerH W de Bruijn, A G van der Zee, J G AaldersPageof 7